G+FLAS Life Sciences
PrivateLast Round
Series C
Sep 3, 2019
Total Funding Raised
$28M
Company Overview
G+FLAS Life Sciences operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series C round in September 2019.
G+FLAS Life Sciences is a biotechnology company that develops new drugs, biopharmaceuticals, and novel seeds based on CRISPR gene editing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
G+FLAS Life Sciences Comparables
Compare G+FLAS Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ToolGen Inc. | 80% | |
| Caszyme | 78% | |
| Pairwise | 68% |
For institutional investors. Book with your work email.
G+FLAS Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 3, 2019 | ||||
| Series B | Jul 19, 2018 | ||||
| Series A | Mar 1, 2017 | ||||
| Seed | Mar 1, 2016 |
For institutional investors. Book with your work email.
G+FLAS Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series C |
| The Wells Investment | Series A |
| ActnerLab | Seed |
| Alpen Route | Series C |
| DS Asset Management | Series B |
| Timefolio Asset Management | Series B |
| Daesung Private Equity | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 169% MoM, reaching 6.2K.
- May 2, 2025
Monthly visitors grew 36% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
G+FLAS Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about G+FLAS Life Sciences's valuation, stock price, and market status.
Is G+FLAS Life Sciences a public or private company?
G+FLAS Life Sciences is a private company.
What is the current stock price of G+FLAS Life Sciences?
G+FLAS Life Sciences is a private company, so its shares have no public market price. Caplight tracks G+FLAS Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is G+FLAS Life Sciences worth (valuation)?
Valuation information for G+FLAS Life Sciences is not publicly available.
Can I buy G+FLAS Life Sciences stock?
G+FLAS Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was G+FLAS Life Sciences's last funding round?
G+FLAS Life Sciences's most recent funding round was Series C on September 3, 2019.
Who are the main investors in G+FLAS Life Sciences?
Key investors in G+FLAS Life Sciences include DS Asset Management.
Will G+FLAS Life Sciences IPO soon?
No public IPO plans have been announced for G+FLAS Life Sciences.
How can I track G+FLAS Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in G+FLAS Life Sciences's shares on secondary markets.